MDM2 and retinoblastoma: One major difference between retinoblastoma and SCLC is that whereas TP53 is mutated in most SCLCs [25], it is functional in most retinoblastomas although the activity of p53 may be weakened by MDM2 or MDM4 overexpression [27].